News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
110,343 Results
Type
Article (7275)
Company Profile (25)
Press Release (103043)
Section
Business (33242)
Career Advice (205)
Deals (5176)
Drug Delivery (10)
Drug Development (11305)
Employer Resources (11)
FDA (3064)
Job Trends (3145)
News (54451)
Policy (5855)
Tag
Academia (723)
Alliances (10876)
Alzheimer's disease (182)
Approvals (3086)
Artificial intelligence (28)
Bankruptcy (28)
Best Places to Work (2467)
Breast cancer (38)
Cancer (310)
Cardiovascular disease (19)
Career advice (187)
CAR-T (38)
Cell therapy (79)
Clinical research (8364)
Collaboration (139)
COVID-19 (723)
C-suite (23)
Cystic fibrosis (18)
Data (284)
Diabetes (21)
Diagnostics (3154)
Drug discovery (17)
Earnings (9493)
Events (11722)
Executive appointments (78)
FDA (3180)
Funding (69)
Gene therapy (112)
GLP-1 (106)
Government (996)
Healthcare (2518)
Infectious disease (743)
Interviews (28)
IPO (1621)
Job creations (804)
Job search strategy (176)
Layoffs (36)
Legal (1151)
Lung cancer (54)
Lymphoma (21)
Manufacturing (58)
Medical device (1385)
Medtech (1385)
Mergers & acquisitions (3592)
Metabolic disorders (37)
Neuroscience (211)
NextGen: Class of 2025 (900)
Non-profit (610)
Northern California (234)
Opinion (19)
People (9830)
Phase I (2919)
Phase II (3465)
Phase III (2996)
Pipeline (83)
Postmarket research (401)
Preclinical (1542)
Press Release (28)
Radiopharmaceuticals (38)
Rare diseases (48)
Real estate (2032)
Regulatory (4015)
Research institute (682)
Resumes & cover letters (21)
Southern California (201)
Startups (673)
United States (2395)
Vaccines (98)
Date
Today (23)
Last 7 days (93)
Last 30 days (338)
Last 365 days (5094)
2025 (330)
2024 (5176)
2023 (6183)
2022 (9767)
2021 (10177)
2020 (9678)
2019 (6802)
2018 (5158)
2017 (5566)
2016 (5539)
2015 (6146)
2014 (4852)
2013 (4294)
2012 (4523)
2011 (4607)
2010 (4115)
Location
Africa (130)
Arizona (24)
Asia (6639)
Australia (1120)
California (544)
Canada (214)
China (29)
Colorado (30)
Connecticut (25)
Delaware (20)
Europe (15727)
Florida (68)
Illinois (41)
Indiana (33)
Kansas (20)
Maine (23)
Maryland (115)
Massachusetts (353)
Michigan (51)
Minnesota (30)
Missouri (19)
New Jersey (241)
New York (177)
North Carolina (143)
Northern California (234)
Ohio (51)
Pennsylvania (108)
South America (188)
Southern California (201)
Texas (137)
Utah (32)
Washington State (81)
110,343 Results for "vector laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
Charles River Laboratories International, Inc. today announced a lentiviral vector contract development and manufacturing organization (CDMO) agreement.
June 25, 2024
·
4 min read
Deals
Vector Laboratories Merges With Absolute Biotech, Significantly Expanding Capabilities as a Critical Component Manufacturer for Life Science Customers
Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, announced its intention to merge with Absolute Biotech, a unified company of multiple antibody-centric brands.
May 15, 2024
·
4 min read
Press Releases
Addgene Expands Viral Vector Service with Packaged on Request
January 10, 2025
·
3 min read
Genetown
Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
Charles River Laboratories International, Inc. today announced a plasmid DNA and retrovirus vector production program agreement.
June 17, 2024
·
4 min read
Business
Vector Laboratories and Navinci Diagnostics Announce Strategic Collaboration to Develop Novel Spatial Proteomic Tools Enabling Biomarker Discovery
Vector Laboratories today announced that they have signed an agreement.
January 30, 2024
·
3 min read
Genetown
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the introduction of its Modular and Fast Track viral vector technology (tech) transfer frameworks.
May 30, 2024
·
4 min read
Press Releases
Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy
January 13, 2025
·
3 min read
Genetown
Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its reference materials for adeno associated virus (AAV) and lentiviral vector (LVV) portfolio, designed to streamline Cell and Gene Therapy (CGT) research and development as it scales to Good Manufacturing Practice- (GMP) quality.
May 2, 2024
·
4 min read
Press Releases
MIP Discovery rebrands as Tozaro as it completes transition to supporting cell and gene therapy viral vector analytics and purification
Tozaro’s rationally designed smart polymer affinity reagents offer novel analytics and purification solutions to enhance the development and manufacture of viral vectors in cell and gene therapy Rebrand follows Series A funding round in February 2024
August 5, 2024
·
2 min read
Press Releases
PulseSight Therapeutics announces the initiation of the clinical plan of PST-611, Transferrin Vectorized Therapy for dry AMD/Geographic Atrophy
January 14, 2025
·
4 min read
1 of 11,035
Next
